Provided by Tiger Trade Technology Pte. Ltd.

uniQure NV

23.46
+0.09000.39%
Post-market: 23.45-0.0100-0.04%18:13 EDT
Volume:1.95M
Turnover:45.44M
Market Cap:1.63B
PE:-5.81
High:23.72
Open:23.72
Low:22.71
Close:23.37
52wk High:71.50
52wk Low:8.73
Shares:69.37M
Float Shares:57.53M
Volume Ratio:0.22
T/O Rate:3.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.0399
EPS(LYR):-3.4602
ROE:-157.61%
ROA:-15.72%
PB:5.02
PE(LYR):-6.78

Loading ...

Why uniQure (QURE) Is Up 72.9% After FDA Backs AMT-130 Data For Accelerated Approval Prospects

Simply Wall St.
·
Jun 19

uniQure Raised to Overweight From Equal-Weight by Barclays

Dow Jones
·
Jun 19

uniQure Is Maintained at Outperform by Leerink Partners

Dow Jones
·
Jun 19

UniQure's Approval Path Looks Stronger After US FDA Feedback, RBC Capital Markets Says

MT Newswires Live
·
Jun 18

uniQure price target raised to $70 from $36 at Leerink

TIPRANKS
·
Jun 18

Analysts Are Bullish on These Healthcare Stocks: uniQure (QURE), Biohaven Ltd. (BHVN)

TIPRANKS
·
Jun 18

uniQure upgraded to Overweight from Equal Weight at Barclays

TIPRANKS
·
Jun 18

RBC Raises Price Target on uniQure to $65 From $35, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Jun 18

Uniqure Nv : Leerink Partners Raises Target Price to $70 From $36

THOMSON REUTERS
·
Jun 18

TD Cowen Sticks to Their Buy Rating for uniQure (QURE)

TIPRANKS
·
Jun 18

uniQure director Madhavan Balachandran disposes of USD 278,500 in common shares

Reuters
·
Jun 18

Under the Radar: uniQure Shares Surge After FDA's Reversal on Gene Therapy -- WSJ

Dow Jones
·
Jun 18

Top Midday Gainers

MT Newswires Live
·
Jun 18

uniQure upgraded to Overweight from Neutral at Cantor Fitzgerald

TIPRANKS
·
Jun 17

BUZZ-U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron

Reuters
·
Jun 17

UniQure Stock (QURE) Rockets on an FDA Update

TIPRANKS
·
Jun 17

This Biotech Stock Is Surging 66% on Surprise Good News From FDA -- Barrons.com

Dow Jones
·
Jun 17

Uniqure Nv : Van Lanschot Kempen Raises Target Price to $60 From $27

THOMSON REUTERS
·
Jun 17

uniQure AMT-130 update ‘materially positive,’ says H.C. Wainwright

TIPRANKS
·
Jun 17

UniQure to Seek FDA Approval to Market Huntington's Disease Drug

Dow Jones
·
Jun 17